Literature DB >> 25904757

Editor's Choice-Chest pain relief in patients with acute myocardial infarction.

Guido Parodi1.   

Abstract

Chest pain is the prevalent symptom at presentation in patients with acute myocardial infarction (AMI). Despite the complete absence of rigorous studies designed to assess the impact of morphine administration in patients with AMI, clinical practice guidelines strongly recommend morphine for analgesia. However, when using morphine to relieve chest pain in AMI patients, physicians must be aware that hypotension, respiratory depression, vomiting, and delayed onset of action of antiplatelet agents are potential unwanted side effects of the drug. The purpose of this report is to review morphine's clinical and side effects and to propose strategies able to reduce chest pain in AMI patients. © The European Society of Cardiology 2015.

Entities:  

Keywords:  STEMI; antiplatelets; chest pain; morphine; myocardial infarction; prasugrel; ticagrelor

Mesh：

Substances：

Year:  2015        PMID： 25904757     DOI： 10.1177/2048872615584078

Source DB:  PubMed          Journal:  Eur Heart J Acute Cardiovasc Care        ISSN： 2048-8726


  4 in total

Review 1.  Risks of Opioids in ST-Elevation Myocardial Infarction: A Review.

Authors:  Anne Henrieke Tavenier; Renicus Suffridus Hermanides; Jan Paul Ottervanger; Peter Gerrit Johannes Ter Horst; Elvin Kedhi; Adriaan W J van 't Hof
Journal:  Drug Saf       Date:  2018-12       Impact factor: 5.606

2.  Pre-hospital treatment of patients with acute coronary syndrome: Recommendations for medical emergency teams. Expert position update 2022.

Authors:  Jacek Kubica; Piotr Adamski; Jerzy R Ładny; Jarosław Kaźmierczak; Tomasz Fabiszak; Krzysztof J Filipiak; Robert Gajda; Mariusz Gąsior; Zbigniew Gąsior; Robert Gil; Jarosław Gorący; Stefan Grajek; Leszek Gromadziński; Marcin Gruchała; Grzegorz Grześk; Piotr Hoffman; Miłosz J Jaguszewski; Marianna Janion; Piotr Jankowski; Zbigniew Kalarus; Jarosław D Kasprzak; Andrzej Kleinrok; Wacław Kochman; Aldona Kubica; Wiktor Kuliczkowski; Jacek Legutko; Maciej Lesiak; Klaudiusz Nadolny; Eliano P Navarese; Piotr Niezgoda; Małgorzata Ostrowska; Przemysław Paciorek; Jolanta Siller-Matula; Łukasz Szarpak; Dariusz Timler; Adam Witkowski; Wojciech Wojakowski; Andrzej Wysokiński; Marzenna Zielińska
Journal:  Cardiol J       Date:  2022-05-06       Impact factor: 3.487

3.  Morphine delays and attenuates ticagrelor exposure and action in patients with myocardial infarction: the randomized, double-blind, placebo-controlled IMPRESSION trial.

Authors:  Jacek Kubica; Piotr Adamski; Małgorzata Ostrowska; Joanna Sikora; Julia Maria Kubica; Wiktor Dariusz Sroka; Katarzyna Stankowska; Katarzyna Buszko; Eliano Pio Navarese; Bernd Jilma; Jolanta Maria Siller-Matula; Michał Piotr Marszałł; Danuta Rość; Marek Koziński
Journal:  Eur Heart J       Date:  2015-10-21       Impact factor: 29.983

4.  Nitrous oxide/oxygen plus acetaminophen versus morphine in ST elevation myocardial infarction: open-label, cluster-randomized, non-inferiority study.

Authors:  Sandrine Charpentier; Michel Galinski; Vincent Bounes; Agnès Ricard-Hibon; Carlos El-Khoury; Meyer Elbaz; François-Xavier Ageron; Stéphane Manzo-Silberman; Louis Soulat; Frédéric Lapostolle; Alexandre Gérard; Delphine Bregeaud; Vanina Bongard; Eric Bonnefoy-Cudraz
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2020-05-12       Impact factor: 2.953
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.